These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 21108965)

  • 1. Construction of a highly-active, liver-specific transcriptional regulatory element through combination of the albumin promoter and α-fetoprotein enhancer.
    Chen EQ; Song XQ; Wang YL; Zhou TY; Bai L; Liu L; Liu C; Cheng X; Tang H
    Plasmid; 2011 Mar; 65(2):125-31. PubMed ID: 21108965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a plasmid vector for liver-specific inhibition of hepatocyte nuclear factor 4 alpha expression.
    Song XQ; Chen EQ; Wang YB; Zhou TY; Liu L; Liu C; Cheng X; Tang H
    Plasmid; 2012 Jan; 67(1):60-6. PubMed ID: 21907733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A; Uto H; Moriuchi A; Nagata K; Onaga Y; Onaga M; Hori T; Hirono S; Hayashi K; Tamaoki T; Tsubouchi H
    Cancer Res; 2001 Apr; 61(7):3016-21. PubMed ID: 11306481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional mapping of tissue-specific elements of the human alpha-fetoprotein gene enhancer.
    Nakabayashi H; Koyama Y; Suzuki H; Li HM; Sakai M; Miura Y; Wong NC; Nishi S
    Biochem Biophys Res Commun; 2004 Jun; 318(3):773-85. PubMed ID: 15144905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The function of 3' noncoding sequences of hepatitis B surface antigen gene in a non-hepatic cell expression system.
    Liu D; Shen X; Tian K
    Chin J Biotechnol; 1993; 9(4):235-40. PubMed ID: 8061232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of HSV-tk/GCV on hepatic specific damage driven by murine ALB promoter/enhancer.
    Zhang Y; Huang SZ; Zeng YT
    Yi Chuan Xue Bao; 2004 Oct; 31(10):1053-60. PubMed ID: 15552038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Construction of pGL3-SM22-SCAP (D443N) eukaryotic expression vector and its expression in CHO cells].
    Wang Y; Hu J; Cui J; Huang A; Ruan X; Chen Y
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):114-20. PubMed ID: 20353101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector.
    Wang D; Wang Z; Tian J; He X; Chowdhury WH; Zhang X; Li S; Rodriguez R
    Urol Oncol; 2010; 28(2):164-9. PubMed ID: 18440837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analyses of albumin expression in a series of hepatocyte cell lines and in primary hepatocytes.
    Hu JM; Camper SA; Tilghman SM; Miller T; Georgoff I; Serra R; Isom HC
    Cell Growth Differ; 1992 Sep; 3(9):577-88. PubMed ID: 1419909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of eukaryotic expression vector expressing hepatitis B virus HBsAg and EGFP fusion protein and establishment of stable transfected Chang Liver cell line].
    Mu JS; Wang HF; Wang JH; Pan XB; Zhang L; Wei L
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):228-30. PubMed ID: 19031712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of HBV DNA replication and expression in 2.2.15 hepatoma cells infected with AFP-mediated HBX antisense RNA].
    Ma CH; Sun WS; Liu SX; Wang XY; Zhang LN; Cao YL; Han LH
    Zhonghua Gan Zang Bing Za Zhi; 2003 May; 11(5):291-4. PubMed ID: 12773245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the human C6 promoter: requirement of the CCAAT enhancer binding protein binding site for C6 gene promoter activity.
    González S; López-Larrea C
    J Immunol; 1996 Sep; 157(6):2282-90. PubMed ID: 8805625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte-specific gene expression from integrated lentiviral vectors.
    Nash KL; Jamil B; Maguire AJ; Alexander GJ; Lever AM
    J Gene Med; 2004 Sep; 6(9):974-83. PubMed ID: 15352070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F; Tsuruta S; Ido A; Ueki T; Nakao K; Kato Y; Tamaoki T; Ishii N; Nakata K
    Cancer Gene Ther; 1998; 5(5):301-6. PubMed ID: 9824049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short and highly efficient synthetic promoters for melanoma-specific gene expression.
    Martinelli R; De Simone V
    FEBS Lett; 2005 Jan; 579(1):153-6. PubMed ID: 15620705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
    Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
    Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoma cell-specific expression of a retrovirally transferred gene is achieved by alpha-fetoprotein but not insulinlike growth factor II regulatory sequences.
    Arbuthnot P; Bralet MP; Thomassin H; Danan JL; Bréchot C; Ferry N
    Hepatology; 1995 Dec; 22(6):1788-96. PubMed ID: 7489990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Construction of a hepatoma-targeting vector of adeno-associated virus containing human alpha-fetoprotein promoter and wild p53 gene in gene therapy of liver cancer].
    Cheng J; Leng X; Peng J
    Zhonghua Yi Xue Za Zhi; 2000 Jun; 80(6):461-3. PubMed ID: 11798803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of artificial chimerical gene regulatory elements specific for cancer gene therapy.
    Shin JH; Yi JK; Lee YJ; Kim AL; Park MA; Kim SH; Lee H; Kim CG
    Oncol Rep; 2003; 10(6):2063-9. PubMed ID: 14534744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.
    Tacke F; Liedtke C; Bocklage S; Manns MP; Trautwein C
    Gut; 2005 Sep; 54(9):1309-17. PubMed ID: 15871998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.